First Cardiac Adult Stem Cell Trial to be at Jewish Hospital
The world’s first phase one, FDA-approved clinical trial using adult cardiac stem cells to treat heart disease will be conducted at Jewish Hospital, part of Jewish Hospital & St. Mary’s HealthCare. The trial will be conducted by a team of University of Louisville doctors. Patients who have advanced heart disease and will undergo bypass surgery will be recruited for participation. During surgery, a small piece of tissue that is routinely removed during the bypass procedure will be frozen and sent to Harvard University, where the cardiac stem cells can be extracted. After the patient recovers, the cells will be injected into cardiac scar tissue using a minimally invasive process. For more information, contact Barbara Mackovic of Jewish Hospital & St. Mary’s HealthCare at email@example.com.